Pharmstandard International S.A. is 10% Owner at ARGOS THERAPEUTICS INC (ARGS). They have made 8 open-market trades across 1 company since 2016, most recently 2017-10-31.
CIK 0001105533
8 open-market purchases totalling $2.0M since 2016, never a sale. Across 8 scored buys the stock is up 3.8% at ninety days, and 1.8 points ahead of the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ARGS | 13,142,784 | $3.5M |
Shares reported on the most recent Form 4, priced at the 2017-11-02 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 38% | 38% | 50% |
| Avg Move | +2.5% | -3.4% | +3.8% |
| Alpha | +3.5% | -2.5% | +1.8% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARGS | BUY | 2016-10-04 | 2016-10-13 | $4.73 | $150K | +0.0% | +6.6% | +22.0% |
| ARGS | BUY | 2016-09-28 | 2016-09-30 | $4.55 | $328K | -6.0% | -16.0% | -2.0% |
| ARGS | BUY | 2016-09-01 | 2016-09-07 | $4.78 | $162K | -11.2% | -12.1% | -11.5% |
| ARGS | BUY | 2016-08-24 | 2016-08-29 | $4.57 | $252K | -6.0% | -12.3% | -5.6% |
| ARGS | BUY | 2016-08-24 | 2016-08-29 | $4.57 | $252K | -6.0% | -12.3% | -5.6% |
| ARGS | BUY | 2016-08-23 | 2016-08-25 | $4.52 | $305K | +16.6% | -0.4% | +8.6% |
| ARGS | BUY | 2016-08-19 | 2016-08-23 | $4.23 | $226K | +16.2% | +9.8% | +12.2% |
| ARGS | BUY | 2016-08-19 | 2016-08-23 | $4.24 | $320K | +16.2% | +9.8% | +12.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.